BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38522903)

  • 1. Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice.
    Furukawa K; Okamoto-Matsuda K; Harada KH; Minata M; Hitomi T; Kobayashi H; Koizumi A
    Environ Health Prev Med; 2024; 29():21. PubMed ID: 38522903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.
    Eldasher LM; Wen X; Little MS; Bircsak KM; Yacovino LL; Aleksunes LM
    Toxicology; 2013 Apr; 306():108-13. PubMed ID: 23435180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abcb4 acts as multixenobiotic transporter and active barrier against chemical uptake in zebrafish (Danio rerio) embryos.
    Fischer S; Klüver N; Burkhardt-Medicke K; Pietsch M; Schmidt AM; Wellner P; Schirmer K; Luckenbach T
    BMC Biol; 2013 Jun; 11():69. PubMed ID: 23773777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
    Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
    Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat.
    Worley RR; Fisher J
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):428-41. PubMed ID: 26522833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4.
    Gautherot J; Durand-Schneider AM; Delautier D; Delaunay JL; Rada A; Gabillet J; Housset C; Maurice M; Aït-Slimane T
    J Biol Chem; 2012 Feb; 287(7):5070-8. PubMed ID: 22184139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice.
    Yu X; Zhang Y; Cogliati B; Klaassen CD; Kumar S; Cheng X; Bu P
    Toxicology; 2024 Feb; 502():153719. PubMed ID: 38181850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.
    Duan Z; Brakora KA; Seiden MV
    Mol Cancer Ther; 2004 Jul; 3(7):833-8. PubMed ID: 15252144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection.
    Kalabis GM; Kostaki A; Andrews MH; Petropoulos S; Gibb W; Matthews SG
    Biol Reprod; 2005 Oct; 73(4):591-7. PubMed ID: 15917342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.
    Cheng X; Klaassen CD
    Toxicol Sci; 2008 Nov; 106(1):37-45. PubMed ID: 18703564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of 11C-Erlotinib.
    Traxl A; Wanek T; Mairinger S; Stanek J; Filip T; Sauberer M; Müller M; Kuntner C; Langer O
    J Nucl Med; 2015 Dec; 56(12):1930-6. PubMed ID: 26359257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abcc6 deficiency in mice leads to altered ABC transporter gene expression in metabolic active tissues.
    Ibold B; Faust I; Tiemann J; Gorgels TGMF; Bergen AAB; Knabbe C; Hendig D
    Lipids Health Dis; 2019 Jan; 18(1):2. PubMed ID: 30611276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
    Morita SY; Terada T
    Biomed Res Int; 2014; 2014():954781. PubMed ID: 25133187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of various ATP-binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC).
    Thoeni C; Perciani CT; Nakib D; Camat D; McGilvray ID; MacParland SA; Fischer S
    Histopathology; 2023 Oct; 83(4):559-568. PubMed ID: 37488782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney.
    Huls M; van den Heuvel JJ; Dijkman HB; Russel FG; Masereeuw R
    Kidney Int; 2006 Jun; 69(12):2186-93. PubMed ID: 16612327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter.
    Robey RW; Robinson AN; Ali-Rahmani F; Huff LM; Lusvarghi S; Vahedi S; Hotz JM; Warner AC; Butcher D; Matta J; Edmondson EF; Lee TD; Roth JS; Lee OW; Shen M; Tanner K; Hall MD; Ambudkar SV; Gottesman MM
    Sci Rep; 2021 Dec; 11(1):24150. PubMed ID: 34921178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone receptor β1 stimulates
    Gautherot J; Claudel T; Cuperus F; Fuchs CD; Falguières T; Trauner M
    J Lipid Res; 2018 Sep; 59(9):1610-1619. PubMed ID: 29895698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
    Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
    Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4.
    Shoda J; Inada Y; Tsuji A; Kusama H; Ueda T; Ikegami T; Suzuki H; Sugiyama Y; Cohen DE; Tanaka N
    J Lipid Res; 2004 Oct; 45(10):1813-25. PubMed ID: 15258199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.